The Effect of FDA Advisories on Branded Pharmaceutical Firms' Valuations and Promotion Efforts
Year of publication: |
2011-10
|
---|---|
Authors: | Conti, Rena M. ; Huskamp, Haiden A. ; Berndt, Ernst R. |
Institutions: | National Bureau of Economic Research (NBER) |
Extent: | application/pdf |
---|---|
Series: | |
Type of publication: | Book / Working Paper |
Notes: | HC LE Number 17528 |
Classification: | d22 ; D43 - Oligopoly and Other Forms of Market Imperfection ; I11 - Analysis of Health Care Markets ; I18 - Government Policy; Regulation; Public Health ; K23 - Regulated Industries and Administrative Law ; L1 - Market Structure, Firm Strategy, and Market Performance ; L11 - Production, Pricing, and Market Structure Size; Size Distribution of Firms |
Source: |
-
Picking Your Patients : Selective Admissions in the Nursing Home Industry
Gandhi, Ashvin, (2021)
-
When Past Is Not Prologue : The Weakness of the Economic Evidence against Health Insurance Mergers
Manne, Geoffrey A., (2017)
-
Implementing Effective Competition Law in the Pharmaceutical Industry in Mexico
Mena-Labarthe, Carlos, (2016)
- More ...
-
Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007
Conti, Rena M., (2014)
-
Early Retirement and Public Disability Insurance Applications: Exploring the Impact of Depression
Conti, Rena M., (2006)
-
Pricing in the Market for Anticancer Drugs
Howard, David H., (2015)
- More ...